NEWSROOM:

PRESS RELEASES

Ascension Sciences Receives R&D License from Health Canada

Ascension Sciences is pleased to announce that it has been issued a Research and Development (“R&D”) license under the Cannabis Act and Cannabis Regulations by Health Canada with a five-year term until August 17, 2025.

Ascension Sciences’ Collaborator Awarded Mitacs Internship through NMIN HQP Program

Ascension Sciences is pleased to announce that collaborator Dr. Farahnaz Fathordoobady has been awarded  a Nanomedicines Innovation Network (NMIN) and Mitacs internship while being accepted into the NMIN Highly Qualified Personnel program (HQP).

Success Story: Ascension Sciences Receives Subsidy to Support Future Talent

As part of the Student Work Placements Program, ASI is proud to be recognized as a VFC Employer and a supporter of the Government’s initiative to create over 10,000 paid student work placements in STEM.

For media inquiries, please contact info@ascensionsciences.com